Anxiety and Depression in Adults with Primary Immunodeficiencies (PID's)--—How Much Do These Patients Experience and What Factors May Increase Patients' Risk?

      Primary Immunodeficiency (PID) is a rare group of disorders that manifest similarly with infection, neoplasms, allergic and autoimmune diseases and are treated with injectable medications. Often the burden of disease and cost of management is excessive and premature death is not uncommon. In light of above features of PID, it was our objective to survey our cohort to assess for additional morbidity from depression and anxiety.
      To read this article in full you will need to make a payment


      Subscribe to Journal of Allergy and Clinical Immunology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect